-

12:05:30 PM

BNTX Stock News

BNTX - BioNTech SE

01/11/22 7:00 AM

Nasdaq : BNTX

BioNTech and InstaDeep Developed and Successfully Tested Early Warning System to Detect Potential High-Risk SARS-CoV-2 Variants

Early Warning System combines Spike protein structural modeling with artificial intelligence (AI) to detect and monitor high-risk SARS-CoV-2 variants, identifying >90% of WHO-designated variants on average two months prior to officially receiving the designation Study introduces a new method of

RHEA-AI

neutral

01/10/22 8:00 AM

Nasdaq : BNTX

BioNTech and Crescendo Biologics Announce Global Collaboration to Develop Multi-specific Precision Immunotherapies

Collaboration leverages BioNTech’s proprietary multimodal immunotherapy expertise with Crescendo’s proprietary Humabody ® V H platform to develop precision immunotherapies, including mRNA-based antibodies and engineered cell therapies against targets selected by BioNTech BioNTech will hold

RHEA-AI

positive

01/05/22 6:45 AM

NYSE, Nasdaq : PFE, BNTX

Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine

Third mRNA vaccine collaboration between the companies aims to accelerate development of an improved vaccine for shingles, a debilitating, disfiguring and painful disease that affects people all over the world Product candidates will be based on BioNTech’ s proprietary mRNA technology and on Pfizer’ s antigen technology Clinical trials are expected to...

RHEA-AI

positive

01/05/22 6:45 AM

Nasdaq : BNTX

Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine

Third mRNA vaccine collaboration between the companies aims to accelerate development of an improved vaccine for shingles, a debilitating, disfiguring and painful disease that affects people all over the world Product candidates will be based on BioNTech’s proprietary mRNA technology and on

RHEA-AI

positive

01/03/22 9:45 AM

NYSE, Nasdaq : PFE, BNTX

covid-19

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older

First emergency use authorization in the United States for a COVID-19 vaccine booster in adolescents 12 through 15 years of age Today’ s FDA action also reduces time between completion of primary series and booster dose for all eligible individuals, and authorizes a third primary series dose for individuals 5 through 11 years of age with certain kinds of...

RHEA-AI

neutral

12/27/21 6:45 AM

Nasdaq : BNTX

conferences

BioNTech to Present at the 40th Annual J.P. Morgan Healthcare Conference

MAINZ, Germany, December 27, 2021 — BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that CEO and Co-founder Ugur Sahin, M.D., will present a corporate overview and update at the virtual 40 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022, at 9:45 am

RHEA-AI

neutral

12/20/21 10:05 AM

NYSE, Nasdaq : PFE, BNTX

Pfizer and BioNTech to Provide European Union More Than 200 Million Additional Doses of COMIRNATY® to Help Meet Continued Need for Vaccine Supply

Pfizer Inc. and BioNTech SE today announced an agreement has been reached with the European Commission and its member states to exercise an option to purchase more than 200 million additional doses of COMIRNATY ®, the companies’ COVID-19 vaccine. Pfizer and BioNTech agreed in May to supply 900 million doses to the European Commission...

RHEA-AI

neutral

12/09/21 12:15 PM

Nasdaq : BNTX

covid-19

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 16 Years and Older

First emergency use authorization in the United States for a COVID-19 vaccine booster in individuals 16 years and older NEW YORK and MAINZ, Germany, December 9, 2021 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) has

RHEA-AI

neutral

12/09/21 12:07 PM

NYSE, Nasdaq : PFE, BNTX

covid-19

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 16 Years and Older

Pfizer Inc. and BioNTech SE today announced that the U.S. Food and Drug Administration has expanded the Emergency Use Authorization of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 16 years of age and older. “Today’ s decision by the FDA to further expand the Emergency Use Authorization of a booster dose of...

RHEA-AI

neutral

12/08/21 7:15 AM

Nasdaq : BNTX

BioNTech to Hold Digital Press Conference to Provide an Update on Omicron Variant

MAINZ, Germany, December 8, 2021 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will hold a digital press conference on Wednesday, December 8, 2021, to present the results from initial laboratory studies which started about two weeks ago. The studies aimed to investigate the effects of

RHEA-AI

neutral

1 2 3 4 5 6 7 8 9 10 Next